ChemicalBook

Гидроксикарбамид

Гидроксикарбамид структура
127-07-1
CAS №
127-07-1
Химическое название:
Гидроксикарбамид
английское имя:
Hydroxyurea
Синонимы:
HYDROXYCARBAMIDE;hu;1-hydroxyurea;hydrea;N-HYDROXYUREA;DROXIA;Siklos;tetratogen: inhibits ribonucleoside diphosphate reductase;NHY;hidrix
CBNumber:
CB8249322
Формула:
CH4N2O2
молекулярный вес:
76.05
MOL File:
127-07-1.mol

Гидроксикарбамид атрибут

Температура плавления: 135-140 °C
Температура кипения: 136.04°C (rough estimate)
плотность: 1.457±0.06 g/cm3(Predicted)
показатель преломления: 1.4840 (estimate)
температура хранения: 2-8°C
растворимость: H2O: 50 мг/мл
форма: пудра
пка: 10.56±0.23(Predicted)
цвет: белый
Запах: odorless or almost odorless
Растворимость в воде: растворимый
Мерк: 14,4848
БРН: 1741548
Стабильность:: Растворы в воде можно хранить при температуре -20°C до 3 месяцев.
Справочник по базе данных CAS: 127-07-1(CAS DataBase Reference)
FDA UNII: X6Q56QN5QC
Словарь онкологических терминов NCI: Droxia; Hydrea; hydroxyurea
Словарь наркотиков NCI: Droxia
Код УВД: L01XX05
МАИР: 3 (Vol. 76) 2000
Предложение 65 Список: Hydroxyurea
Система регистрации веществ EPA: Hydroxyurea (127-07-1)
безопасность
  • Заявления о рисках и безопасности
  • код информации об опасности(GHS)
Коды опасности T,Xn
Заявления о рисках 46-63-61-40
Заявления о безопасности 53-36/37-45-36-22
РИДАДР 2811
WGK Германия 3
RTECS YT4900000
Примечание об опасности Toxic
Класс опасности 6.1
Группа упаковки III
кода HS 29242100
Банк данных об опасных веществах 127-07-1(Hazardous Substances Data)
Токсичность dog,LD50,intravenous,> 1gm/kg (1000mg/kg),Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992.
символ(GHS) GHS hazard pictograms
сигнальное слово Danger
Заявление об опасности
пароль Заявление об опасности Класс опасности категория сигнальное слово пиктограмма предупреждение
H361 Предполагается, что данное вещество может отрицательно повлиять на способность к деторождению или на неродившегося ребенка. Репродуктивная токсичность Категория 2 Предупреждение P201, P202, P281, P308+P313, P405,P501
H340 Может вызывать генетические дефекты. Мутагенность половых клеток Категория 1А, 1Б Опасность GHS hazard pictograms
Внимание
P201 Беречь от тепла, горячих поверхностей, искр, открытого огня и других источников воспламенения. Не курить.
P308+P313 ПРИ подозрении на возможность воздействия обратиться за медицинской помощью.

Гидроксикарбамид MSDS


Hydroxyurea

Гидроксикарбамид химические свойства, назначение, производство

Химические свойства

Off-White Crystalline Solid

Использование

An anti-neoplastic - inhibits ribonucleoside reductase and DNA replication. A potential therapy for sickle cell anemia which involves the nitrosylation of sickle cell hemoglobin. Horseradish peroxidase catalyzes nitric oxide formation from hydroxyurea in the presence of hydrogen peroxide.

Показания

Hydroxyurea (Hydrea) inhibits the enzyme ribonucleotide reductase and thus depletes intracellular pools of deoxyribonucleotides, resulting in a specific impairment of DNA synthesis. The drug therefore is an Sphase specific agent whose action results in an accumulation of cells in the late G1- and early S-phases of the cell cycle.

Общее описание

HONH-CO-NH2. The drug is available in a 500-mg capsulefor oral use. Hydroxyurea is often considered an antimetabolitedrug, and it is used to treat myelogenousleukemia, ovarian cancer, and essential thrombocytosis. Themechanism of action of hydroxyurea involves inhibition ofDNA biosynthesis by inhibition of the enzyme ribonucleotidereductase). Resistance can occur viaincreased expression of ribonucleotide reductase. The oralbioavailability is quite high approaching 100% and the drugis distributed to all tissues. Hydroxyurea readily enters theCNS and distributes to human breast milk. A major portionof the total dose is excreted unchanged in the urine. Thedrug has been shown to increase the toxicity of 5-FU, andhydroxyurea may increase the effectiveness of some antimetaboliteHIV drugs. The toxicity profile includes myelosuppression,leucopenia, nausea, vomiting, pruritus hyperpigmentation,headache, drowsiness, and confusion.

Реакции воздуха и воды

Water soluble.

Профиль реактивности

An amide. Amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents. Amides are very weak bases (weaker than water). Mixing amides with dehydrating agents such as P2O5 or SOCl2 generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx).

Пожароопасность

Flash point data for Hydroxyurea are not available; however, Hydroxyurea is probably combustible.

Механизм действия

Hydroxyurea is rapidly absorbed after oral administration, with peak plasma levels achieved approximately 1 to 2 hours after drug administration; its elimination half-life is 2 to 3 hours. The primary route of excretion is renal, with 30 to 40% of a dose excreted unchanged.

Клиническое использование

Hydroxyurea is used for the rapid lowering of blood granulocyte counts in patients with chronic granulocytic leukemia. The drug also can be used as maintenance therapy for patients with the disease who have become resistant to busulfan. Only a small percentage of patients with other malignancies have had even brief remissions induced by hydroxyurea administration.

Побочные эффекты

Hematological toxicity, with white blood cells affected more than platelets, may occur. Megaloblastosis of the bone marrow also may be observed. Recovery is rapid, generally within 10 to 14 days after discontinuation of the drug. Some skin reactions, including hyperpigmentation and hyperkeratosis, have been reported with chronic treatment.

Метаболизм

Hydroxyurea has excellent oral bioavailability (80–100%), and serum levels peak within 2 hours of consuming the capsules. If a positive response is noted within 6 weeks, toxicities generally are mild enough to permit long-term or indefinite therapy on either a daily or every-3-day basis. Leukopenia and, less commonly, thrombocytopenia and/or anemia are the most serious adverse effects. Excretion of the unchanged drug and the urea metabolite is via the kidneys. The carbon dioxide produced as a by-product of hydroxyurea metabolism is excreted in the expired air.

Методы очистки

Recrystallise hydroxyurea from absolute EtOH (10g in 150mL). Note that the rate of solution in boiling EtOH is slow (15-30minutes). It should be stored in a cool dry place, but some decomposition could occur after several weeks. [Deghenghi Org Synth Coll Vol V 645 1973.] It is very soluble in H2O and can be crystallised from Et2O. [Kfod Acta Chem Scand 10 256 1956, Beilstein 3 IV 170.]

Гидроксикарбамид препаратная продукция и сырье

сырьё

препарат


Гидроксикарбамид поставщик

Global( 463)Suppliers
поставщик телефон страна номенклатура продукции благоприятные условия
Hebei Chuanghai Biotechnology Co,.LTD
+86-13131129325
China 5867 58
Hangzhou Verychem Science And Technology Co.Ltd
+86-86-57188162785 13606544505
China 1037 58
Mainchem Co., Ltd.
--
China 6572 58
Amadis Chemical Company Limited
571-89925085
China 131980 58
Watson Biotechnology Co.,Ltd
+86-18186686046 +86-18186686046
China 5851 58
Xiamen Eagle Chemical Limited Corporation
+86-5925023701 +86-18900207489
China 6044 58
Shanghai Likang New Materials Co., Limited
+86-16631818819 +86-17736933208
China 9311 58
Aladdin Scientific
+1-+1(833)-552-7181
United States 57511 58
Shanghai Acmec Biochemical Technology Co., Ltd.
+undefined18621343501
China 33350 58
Henan Fengda Chemical Co., Ltd
+86-371-86557731 +86-13613820652
China 20294 58

127-07-1(Гидроксикарбамид)подобный поиск:

Copyright 2017 © ChemicalBook. All rights reserved